Targeting TRPM2 Channels Impairs Radiation-Induced Cell Cycle Arrest and Fosters Cell Death of T Cell Leukemia Cells

Dominik Klumpp1, Milan Misovic1, Kalina Szteyn2

  • 1Department of Radiation Oncology, University of Tübingen, 72076 Tübingen, Germany.

Insights

Ionizing radiation increases T cell leukemia cell survival via the cation channel TRPM2 and the anti-apoptotic protein Bcl-2. Inhibiting TRPM2 triggers cell death, highlighting TRPM2

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The cation channel TRPM2 is correlated with the antiapoptotic protein Bcl-2 in lymphohematopoietic cancers.
  • Bcl-2 overexpression is common in tumors and contributes to therapy resistance.
  • Understanding the interaction between Bcl-2 and TRPM2 is crucial for T cell leukemia treatment.

Purpose of the Study:

  • To investigate the crosstalk between Bcl-2 and TRPM2 channels in T cell leukemia under oxidative stress induced by ionizing radiation (IR).
  • To determine the role of TRPM2 in DNA damage response and cell cycle progression in the context of Bcl-2 overexpression.

Main Methods:

  • Comparing TRPM2 inhibition/knock-down effects on Jurkat cells (Bcl-2 overexpressing vs. empty vector) after IR exposure (0-10 Gy).
  • Assessing plasma membrane currents, calcium (Ca2+) signaling, mitochondrial superoxide anion formation, and cell cycle progression.
  • Utilizing techniques like Western blotting and flow cytometry to analyze cellular responses.

Main Results:

  • Ionizing radiation stimulated a TRPM2-mediated Ca2+ influx, which was significantly higher in Bcl-2 overexpressing cells.
  • This elevated Ca2+ entry contributed to IR-induced G2/M cell cycle arrest.
  • TRPM2 inhibition led to a release from G2/M arrest and subsequent cell death.
  • Bcl-2 overexpressing cells exhibited higher TRPM2 activity without increased mitochondrial superoxide anion formation.

Conclusions:

  • TRPM2 plays a pivotal role in the DNA damage response of T cell leukemia cells.
  • The interplay between Bcl-2 and TRPM2 influences cell cycle arrest and survival following IR.
  • Targeting TRPM2 presents a potential therapeutic strategy for T cell leukemia, particularly in cases of Bcl-2 overexpression.